From: p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics
Gene | Source | Treatment | Case/control | Up/downa | Ref |
---|---|---|---|---|---|
IL-8 | 16HBE Cell line | H2O2/TNF-α + IL-1β + INFγ/LPS | H2O2/TNF-α + IL-1β + INFγ/LPS vs. baseline | Down-G | [50] |
NFkB p65 | 16HBE Cell line | H2O2/TNF-α + IL-1β + INFγ/LPS | H2O2/TNF-α + IL-1β + INFγ/ baseline with LPS | Down-G | [50] |
IL-10 | MH-S cell line | GOLD III/IV serum + LPS + SB203580 | GOLD III/IV serum + LPS + SB203580/ GOLD III/IV serum + LPS | Up-P | [43] |
CCL-5 | MH-S cell line | GOLD IV COPD serum + LPS + SB203580 | GOLD III and IV COPD serum + LPS + SB203580/ GOLD III and IV COPD serum + LPS | Down-P | [43] |
TNFα | MH-S cell line | GOLD III and IV COPD serum + LPS + SB203580 | GOLD III and IV COPD serum + LPS + SB203580/ GOLD III and IV COPD serum + LPS | Down-P | [43] |
GRP-78 | A549 cells | SB203580 + CS | SB203580 + CS/CS | Down-G&P | [81] |